Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NTC chondrograft versus arthroscopic microfracture for symptomatic knee cartilage defects
2017-002601-35Phase 2Completed
- Sponsor
- PrimeCell Advanced Therapy
- Start
- Nov 2017
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of NTC chondrograft in cartilage defect of knee (2 arms), sponsored by PrimeCell Advanced Therapy. Primary endpoint: Co-primary endpoint. Started Nov 2017; status: completed.
02
Drugs
NTC chondrograft
03
Conditions
cartilage defect of knee
Beyond the preview
Go deeper on 2017-002601-35.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-002601-35.